Page last updated: 2024-08-23

paclitaxel and Leukemia, Myelomonocytic, Chronic

paclitaxel has been researched along with Leukemia, Myelomonocytic, Chronic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hu, ZB; McCulloch, EA; Minden, MD; Stahl, J1

Other Studies

1 other study(ies) available for paclitaxel and Leukemia, Myelomonocytic, Chronic

ArticleYear
Regulation of drug sensitivity by ribosomal protein S3a.
    Blood, 2000, Feb-01, Volume: 95, Issue:3

    Topics: Animals; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line; Cryopreservation; Cytarabine; DNA Replication; DNA, Neoplasm; Doxorubicin; Drug Resistance, Neoplasm; Gene Targeting; Humans; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Chronic; Neoplasm Proteins; Neoplastic Stem Cells; Paclitaxel; Phosphorylation; Phosphoserine; Protein Processing, Post-Translational; Rats; Ribosomal Proteins; Tissue Preservation; Treatment Outcome; Tretinoin

2000